The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Adverum Biotechnologies Inc shares valued at $5,920 were sold by Soparkar Peter on May 15 ’25. At $2.00 per share, Soparkar Peter sold 2,960 shares. The insider’s holdings dropped to 39,154 shares worth approximately $89662.66 following the completion of this transaction.
Also, Seyedkazemi Setareh sold 924 shares, netting a total of over 1,848 in proceeds. Following the sale of shares at $2.00 each, the insider now holds 13,768 shares.
Before that, Fischer Laurent had sold 9,126 shares from its account. In a trade valued at $18,252, the CEO, PRESIDENT AND DIRECTOR traded Adverum Biotechnologies Inc shares for $2.00 each. Upon closing the transaction, the insider’s holdings decreased to 9,126 shares, worth approximately $0.2 million.
As published in their initiating research note from Oppenheimer on June 25, 2024, Adverum Biotechnologies Inc [ADVM] has been an Outperform and the price target has been revised to $25. Analysts at H.C. Wainwright started covering the stock with ‘”a Buy”‘ outlook in a report released in late April. As of July 07, 2022, Truist has increased its “Hold” rating to a “Buy” for ADVM. Earlier on July 23, 2021, Cantor Fitzgerald downgraded its rating. Their new recommendation was “a Neutral” for ADVM stock which previously was a “an Overweight”.
Analyzing ADVM Stock Performance
On last trading session,, Adverum Biotechnologies Inc [NASDAQ: ADVM] plunged -1.29% to $2.29. The stock’s lowest price that day was $2.21, but it reached a high of $2.455 in the same session. During the last five days, there has been a drop of approximately -11.58%. Over the course of the year, Adverum Biotechnologies Inc shares have dropped approximately -50.96%. Shares of the company reached a 52-week high of $5.72 on 03/21/25 and a 52-week low of $1.78 on 05/15/25.
Support And Resistance Levels for Adverum Biotechnologies Inc (ADVM)
According to the 24-hour chart, there is a support level at 2.18, which, if violated, would cause prices to drop to 2.07. In the upper region, resistance lies at 2.43. The next price resistance is at 2.56. RSI (Relative Strength Index) is 41.10 on the 14-day chart, showing neutral technical sentiment.
Is Adverum Biotechnologies Inc subject to short interest?
Stocks of Adverum Biotechnologies Inc saw a sharp rise in short interest on 2025-05-30 jumping by 0.46 million shares to 1.94 million. Data from Yahoo Finance shows that the short interest on 2025-04-30 was 1.48 million shares. A jump of 23.74% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 4.46 of the overall float, the days-to-cover ratio (short ratio) jumped to 4.46.
Which companies own the most shares of Adverum Biotechnologies Inc (ADVM)?
In terms of Adverum Biotechnologies Inc share price expectations, FactSet research, analysts set an average price target of 15 in the next 12 months, up nearly 546.55% from the previous closing price of $2.32. Analysts anticipate Adverum Biotechnologies Inc stock to reach 28 by 2025, with the lowest price target being 2. In spite of this, 2 analysts ranked Adverum Biotechnologies Inc stock as Buy at the end of 2025. On May 03, 2021, SVB Leerink assigned a price target of “a Mkt perform” to the stock and downgraded coverage with a $5.
